Hide Board Information

Show Board Information

Humacyte, Inc. HUMA

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/02/2025 8:14:59 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 6

Humacyte, Inc. (NASDAQ: HUMA) Stock Message Board

1. HUMA Company Profile

    

2. HUMA Time & Sales

    

3. HUMA Recent News

    

4. HUMA Filings

    

5. HUMA Financials

    

6. HUMA Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

3	1. Assigned Priority Review Designation by	Rubraquercus	01/02/2025 8:14:59 AM
2	In 2010, the HUMA co-founder and CEO, Dr. Laura	Rubraquercus	01/02/2025 7:29:27 AM
1	HUMA 26% v3,4M c4.40 f103M H4.53	znewcar1	08/11/2022 10:04:10 PM

Recent Articles

• Analyzing the Impact of Global Events on Currency Strength
• Navigating Tariff Challenges for Corporate Profitability Ahead
• Insights on RIKB 38 0215 Treasury Bond Auction Outcomes
• Novonesis Executive Transition: Jacob Paulsen Steps Down
• Prosafe SE Announces Key Updates on Vessel Operations
• Faraday Future Advances AI and Vehicle Testing in Los Angeles
• PagBank Reports Record R$2.3 Billion Profit in Fourth Quarter
• Micron Technology, Inc. Faces Class Action Lawsuit: Key Insights
• Class Action Lawsuit Filed for BioAge Labs, Inc. Investors
• Key Financial Press Releases: Must-Read Highlights This Week
• Florida Tech Unveils Vertex Innovation Hub and Leadership
• Market Insights: GTA's Unique Home Buying Opportunities
• SELARSDI: A New Biosimilar Launch by Teva and Alvotech
• CLEAR Declares Dividends and Increases Share Repurchase Plan
• Details of Nilfisk Holding A/S Annual General Meeting Announcement
• SELARSDI™ Launches in the U.S.: A New Era for Patients
• SELARSDI Injection Launch: A Milestone for Teva and Alvotech
• Essential Details of the Upcoming Tryg A/S Annual Meeting
• Huize Leads Insurance Innovation with AI Integration for Consumers
• Rivian Automotive Faces Financial Challenges Despite Earnings Gains
• Five9 Experiences Significant Stock Surge Amid Positive Earnings
• Comparing Investment Returns: Bitcoin ETF vs Invesco QQQ
• NaaS Technology Implements $10 Million Share Buyback Initiative
• Trio Schools' Managing Director Honored with BW Award for Innovation
• PagBank Achieves Record Growth and Profitability in 2024
• Northstake Integrates Lido’s stVaults for Enhanced Liquidity
• Innovative Partnership: Namibox and Hisense Launch Learning Screen
• Nano Labs Unveils Private Equity Sale and Bitcoin Expansion
• PagBank Reports Outstanding Performance with Record Profits
• Senao Networks Launches Innovative AI PC for Better Computing
• i-80 Gold Corp's Exciting Assessment of Mineral Point Project
• Key Highlights from Recent Press Releases: Week Overview
• Arconic Corporation Faces Class Action Amid Securities Claims
• Investors Alert: Class Action Filed for Neumora Securities
• Class Action Lawsuit Update for Novo Nordisk A/S Investors
• Grocery Outlet Investors Should Be Aware of Class Action Notice
• Levi & Korsinsky Initiates Class Action for Crocs Shareholders
• Class Action Lawsuit Filed Against FTAI Aviation Ltd. Shareholders
• Join the Class Action Against AstraZeneca PLC for Investor Recovery
• Class Action Lawsuit Filed Against Block, Inc. for Investors
• Yaqrit Appoints New Leadership to Transform Liver Disease Care
• Upcoming Plaintiff Deadline for Monolithic Power Systems' Case
• Apple's Upcoming iPhone Visual Intelligence Enhancements Explained
• Levi & Korsinsky Addresses Cardlytics, Inc. Lawsuit Concerns
• Newmont Corporation Faces Class Action Lawsuit: Know Your Rights
• Investors Allege Fraud Against Innovative Industrial Properties
• Join the Class Action Against Walgreens: Key Information Inside
• Integral Ad Science Shareholder Lawsuit: What You Need to Know
• ESSA Pharma Inc. Faces Class Action: Learn Your Rights
• Pacira BioSciences Investors Invited to Join Class Action Lawsuit